S Masson1, N Agabiti2, T Vago3, M Miceli4, F Mayer2, T Letizia3, U Wienhues-Thelen5, G F Mureddu6, M Davoli2, A Boccanelli6, R Latini1. 1. Department of Cardiovascular Research, IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy. 2. Lazio Regional Health Service, Rome, Italy. 3. Laboratory of Endocrinology, Ospedale Luigi Sacco, Milan, Italy. 4. ASL Roma D, Rome, Italy. 5. Roche Diagnostics, Penzberg, Germany. 6. Department of Cardiovascular Diseases, S. Giovanni-Addolorata Hospital, Rome, Italy.
Abstract
OBJECTIVES: Fibroblast growth factor-23 (FGF-23) and vitamin D are hormones involved in phosphate homoeostasis. They also directly influence cardiomyocyte hypertrophy. We examined whether the relationships between levels of vitamin D or FGF-23, cardiac phenotype and outcome were independent of established cardiac biomarkers in a large cohort of community-dwelling elderly subjects. DESIGN AND SETTING: Plasma levels of FGF-23 and vitamin D were measured in 1851 men and women (65-84 years) resident in the Lazio region of Italy. Participants were referred to eight cardiology centres for clinical examination, electrocardiography, comprehensive Doppler echocardiography and blood sampling. All-cause mortality or hospitalizations were available after a median follow-up of 47 months with record linkage of administrative data. RESULTS: Vitamin D deficiency (<20 ng mL(-1) ) was found in 72.3% of subjects, but FGF-23 levels were normal [74 (58-97) RU per mL]. After adjustment for cardiovascular risk factors and morbidities, low concentrations of vitamin D and high levels of FGF-23 were associated with a higher left ventricular (LV) mass index. Levels of FGF-23 [hazard ratio (HR) (95% confidence interval (CI)) 1.71 (1.28-2.28), P < 0.0001] but not vitamin D [0.76 (0.57-1.01), P = 0.08] were independently associated with mortality after adjustment for clinical risk factors and two cardiac markers together (N-terminal pro-brain natriuretic peptide and high-sensitivity cardiac troponin T), but did not predict hospital admission. People with above median values of FGF-23 and below median values of vitamin D had greater LV hypertrophy and higher mortality. CONCLUSIONS: In community-dwelling elderly individuals with highly prevalent vitamin D deficiency, FGF-23 levels were associated with LV hypertrophy and predicted mortality independently of two robust cardiac biomarkers. A causal relationship was not demonstrated, but the hormones involved in mineral metabolism emerged as nontraditional risk factors and may affect cardiovascular risk.
OBJECTIVES:Fibroblast growth factor-23 (FGF-23) and vitamin D are hormones involved in phosphate homoeostasis. They also directly influence cardiomyocyte hypertrophy. We examined whether the relationships between levels of vitamin D or FGF-23, cardiac phenotype and outcome were independent of established cardiac biomarkers in a large cohort of community-dwelling elderly subjects. DESIGN AND SETTING: Plasma levels of FGF-23 and vitamin D were measured in 1851 men and women (65-84 years) resident in the Lazio region of Italy. Participants were referred to eight cardiology centres for clinical examination, electrocardiography, comprehensive Doppler echocardiography and blood sampling. All-cause mortality or hospitalizations were available after a median follow-up of 47 months with record linkage of administrative data. RESULTS:Vitamin D deficiency (<20 ng mL(-1) ) was found in 72.3% of subjects, but FGF-23 levels were normal [74 (58-97) RU per mL]. After adjustment for cardiovascular risk factors and morbidities, low concentrations of vitamin D and high levels of FGF-23 were associated with a higher left ventricular (LV) mass index. Levels of FGF-23 [hazard ratio (HR) (95% confidence interval (CI)) 1.71 (1.28-2.28), P < 0.0001] but not vitamin D [0.76 (0.57-1.01), P = 0.08] were independently associated with mortality after adjustment for clinical risk factors and two cardiac markers together (N-terminal pro-brain natriuretic peptide and high-sensitivity cardiac troponin T), but did not predict hospital admission. People with above median values of FGF-23 and below median values of vitamin D had greater LV hypertrophy and higher mortality. CONCLUSIONS: In community-dwelling elderly individuals with highly prevalent vitamin D deficiency, FGF-23 levels were associated with LV hypertrophy and predicted mortality independently of two robust cardiac biomarkers. A causal relationship was not demonstrated, but the hormones involved in mineral metabolism emerged as nontraditional risk factors and may affect cardiovascular risk.
Authors: Amarnath Marthi; Killian Donovan; Richard Haynes; David C Wheeler; Colin Baigent; Christopher M Rooney; Martin J Landray; Sharon M Moe; Jun Yang; Lisa Holland; Romina di Giuseppe; Annet Bouma-de Krijger; Borislava Mihaylova; William G Herrington Journal: J Am Soc Nephrol Date: 2018-05-15 Impact factor: 10.121
Authors: Nisha Bansal; Leila Zelnick; Cassianne Robinson-Cohen; Andy N Hoofnagle; Joachim H Ix; Joao A Lima; Abigail B Shoben; Carmen A Peralta; David S Siscovick; Bryan Kestenbaum; Ian H de Boer Journal: J Am Heart Assoc Date: 2014-12-02 Impact factor: 5.501
Authors: Noreen van der Linden; Lieke J J Klinkenberg; Otto Bekers; Luc J C van Loon; Marja P van Dieijen-Visser; Maurice P Zeegers; Steven J R Meex Journal: Medicine (Baltimore) Date: 2016-12 Impact factor: 1.889
Authors: Dorien M Kimenai; Remy J H Martens; Jeroen P Kooman; Coen D A Stehouwer; Frans E S Tan; Nicolaas C Schaper; Pieter C Dagnelie; Miranda T Schram; Carla J H van der Kallen; Simone J S Sep; Jeroen D E van Suijlen; Abraham A Kroon; Otto Bekers; Marja P van Dieijen-Visser; Ronald M A Henry; Steven J R Meex Journal: Sci Rep Date: 2017-07-26 Impact factor: 4.379
Authors: Alicia K Heath; Iris Y Kim; Allison M Hodge; Dallas R English; David C Muller Journal: Int J Environ Res Public Health Date: 2019-01-29 Impact factor: 3.390
Authors: Jonathan P Law; Anna M Price; Luke Pickup; Ashwin Radhakrishnan; Chris Weston; Alan M Jones; Helen M McGettrick; Winnie Chua; Richard P Steeds; Larissa Fabritz; Paulus Kirchhof; Davor Pavlovic; Jonathan N Townend; Charles J Ferro Journal: J Am Heart Assoc Date: 2020-03-26 Impact factor: 5.501